Please ensure Javascript is enabled for purposes of website accessibility

SEC Filing Details

Document Details

Form
Filing Date
Jan 10, 2025
Document Date
Jan 8, 2025
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Apellis Pharmaceuticals, Inc.
Issuer
APELLIS PHARMACEUTICALS, INC.
Filer
WALBERT KELI